# Sitagliptin Phosphate

NDC: 0781-5768
Generic name: Sitagliptin Phosphate
Labeler / Manufacturer: Sandoz Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20260114

FDA application: ANDA202387

## Active ingredients

- SITAGLIPTIN PHOSPHATE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0781-5768"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0781-5768
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cebc8388-c9db-4e27-8d6b-0d9bdc9d766d